French president Emmanuel Macron has pledged to work with the US to contain Iran, hours after Donald Trump issued a tough warning against Tehran restarting its nuclear programme even if the US pulled out of an existing multi-party accord.
Amgen, the world’s largest biotech company, saw revenue inch higher in the first three months of 2018, with strong growth for recently launched products like its Repatha cholesterol medication softening a decline in sales of some of its more established ones.
Japan’s Takeda Pharmaceuticals is nearing a preliminary agreement to acquire Irish drugmaker Shire for more than $62bn, in what would be the largest deal in sector this year, said people familiar with the matter.
US chipmaker Texas Instruments posted solid double-digit growth in both sales and profit in the first three months of 2018, citing strong demand for its products in the industrial and automotive markets.
US equities ended Tuesday deep in the red for their biggest one-day fall since April 6, with tech and industrial stocks proving the biggest laggards, while US Treasury yields ended just shy of the 3 per cent milestone they crossed earlier in the day for the first time since 2014.
3M shares have peeled back easier than their ubiquitous Post-it notes and are on track for one of their biggest one-day drops in decades after the company dialed back its earnings forecasts for the year.
Wells Fargo avoided a widespread revolt at an at-times heated annual meeting on Tuesday, although a sizeable minority of investors in the scandal-hit US bank voted in favour of two shareholder motions that the board opposed.
The chair of the influential Treasury select committee Nicky Morgan railed against the “litany of failures of banking IT systems” on Tuesday, as customers at two different banks were left unable to access their funds.